The Fröhling/Scholl Lab is part of the Department of Internal Medicine III (Hematology, Oncology, Rheumatology, and Infectious Diseases)
at the University Hospital of Ulm, Germany. The main interest of our research is
to gain deeper understanding of the molecular alterations underlying cancer development, with the ultimate goal to identify
novel therapeutic targets. The
Department of Internal Medicine III offers a highly
interactive and collaborative scientific environment with a strong
focus on translational oncology research. The presence of
internationally renowned clinical programs and some of the largest
collections of primary samples from patients with various hematologic malignancies offer unique opportunities
for creative collaboration at the laboratory/clinical interface.
|
|
